➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Boehringer Ingelheim
Dow
Moodys
Johnson and Johnson

Last Updated: September 28, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: MESALAMINE


Email this page to a colleague

« Back to Dashboard

MESALAMINE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Apil DELZICOL mesalamine CAPSULE, DELAYED RELEASE;ORAL 204412 NDA Allergan, Inc. 0023-5853-18 180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0023-5853-18) 2016-05-16
Apil DELZICOL mesalamine CAPSULE, DELAYED RELEASE;ORAL 204412 NDA A-S Medication Solutions 50090-3002-0 180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (50090-3002-0) 2016-05-16
Apil DELZICOL mesalamine CAPSULE, DELAYED RELEASE;ORAL 204412 NDA AUTHORIZED GENERIC Greenstone LLC 59762-0117-1 180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (59762-0117-1) 2019-05-10
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Harvard Business School
Dow
Mallinckrodt
Moodys